Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Freegold Intersects 2.72 g/t Au over 139.9 metres at Golden Summit (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Agile Therapeutics Equity Warrants
AGXRW
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. Its product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Its initial product, Twirla, (levonorgestrel and ethinyl estradiol), a transdermal system...
, is a non-daily prescription contraceptive. Twirla is based on its proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. Twirla (levonorgestrel and ethinyl estradiol) transdermal system is a once-weekly combined hormonal contraceptive (CHC) patch that contains the active ingredients levonorgestrel (LNG), a type of progestin, and ethinyl estradiol (EE), a type of estrogen. Its potential product pipeline consists of two types of product candidates: a progestin-only (P-only) contraceptive patch and potential Twirla line extensions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:AGXRW)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
Next
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 01, 2023 10:57am
AGRX.....might the 1st move past $3 in a while
Thin to win
(69)
•••
Iseneschal
X
Comment by
Iseneschal
on Aug 01, 2023 9:19am
RE:AGRX ....Place your bets ; )
8 days and counting ....place ur bets Cheers!
Benton Intersects 22.0 m Grading 7.47% Copper Including 8.0 m Grading 11.93%
posted Jan 21, 2025 9:00am by
Benton Resources Inc.
-
|
Grades and widths of this calibre are exceptionally rare in our industry. Confirming gold and copper mineralization in a parallel zone that is associated with an unsourced strong conductor has our team extremely excited ...read more
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 26, 2023 12:16pm
AGRX...Mr. M playin with it again ; )
Anyone care to guess what the ER will bring???
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 26, 2023 11:28am
AGRX ....Place your bets ; )
Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023 2023-07-26 05:30 PT - News Release PRINCETON, N.J., July 26, 2023
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 26, 2023 8:30am
New Press Release - Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023
Live Conference Call and Webcast at 8:30 a.m. ET PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2023 financial results before the market open on Wednesday, August 9, 2023...
read article.
(69)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 19, 2023 1:51pm
RE:AGRX....Ya NR this a.m.....Yawn !!!!!!!!!!!!!
Worth a repeat? U betcha ; ) that NR #7 since the volume & price pop on 06/14 The only ones that benefitted were the "Pros" trading AH before retail got a chance to prosper. Such is
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 19, 2023 9:00am
New Press Release - This Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions of Women Thanks to a Partnership With Afaxys
PRINCETON, NJ / ACCESSWIRE / July 19, 2023 / Agile Therapeutics, Inc.'s (NASDAQ:AGRX) partnership with Afaxys Pharma is expected to play a key role in propelling the women's healthcare company toward its $25-$30 million net annual revenue target for 2023. The companies teamed up last year to make...
read article.
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 18, 2023 1:12pm
AGRX....The bid was worth nothing.... LoL
My last post was removed....here is the meat of the post Remember..... All warfare is based on DECEPTION ; ) This is going to be a winner.....IMHO
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 18, 2023 11:49am
AGRX....This a.m's NR slid right past me
No wonder there was a little action ; ) Well ...back over $3....and on it's way to $10 Cheers !
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 18, 2023 9:02am
New Press Release - Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women
PRINCETON, NJ / ACCESSWIRE / July 18, 2023 / This month, Agile Therapeutics, Inc. (NASDAQ:AGRX) announced partnerships with FPA Women's Health and vitaCare Prescription Services that will expand access to Twirla® (levonorgestrel and ethinyl estradiol) transdermal system, its low-dose weekly birth...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 11, 2023 9:15am
New Press Release - Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden's Latest Executive Order Expanding Contraceptive Coverage
PRINCETON, NJ / ACCESSWIRE / July 11, 2023 / - In June, President Biden issued an Executive Order on Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services. It directs the Secretaries of Health and Human Services (HHS), Labor and the Treasury to issue new...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 05, 2023 9:01am
New Press Release - H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch
PRINCETON, NJ / ACCESSWIRE / July 5, 2023 / H.C. Wainwright & Co, reiterated its buy rating on Agile Therapeutics, Inc. (NASDAQ:AGRX) this month, setting a price target of $12 per share. The $12 price target is based on the 1:50 reverse split and the $7.5 million raised in Agile's public offering...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 03, 2023 9:03am
New Press Release - This Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023
Agile Says Growing Demand For Twirla (levonorgestrel and ethinyl estradiol ) transdermal system Is Helping It Stay On Track to Hit $25-$30 Million Net RevenuePRINCETON, NJ / ACCESSWIRE / July 3, 2023 / Agile Therapeutics (NASDAQ:AGRX) announced the closing of its public offering in May. The women...
read article.
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 9:22am
AGRX..make note: Mr. Maggot doesn't cater to Retail Traders
Check past history.....however.....things will change Just an observation
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 9:10am
AGRX.... Read the previous post for NR
Buy hold and prosper
Prev
1
2
3
4
5
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Alphamin Announces Record Fy2024 & Q4 2024 Tin Production Fy2025 Production Guidance Exploration Success
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*
Eminent's First Drill Hole Hits Significant Gold-Arsenic in Getchell Trend Analogue and Second Hole Drilling Commences
U.S. DOD Logistics Agency Highlights V.GPH Project to Develop Eco-Friendly Graphite-Based Fire-Fighting Material
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.